Feb 24, 2026 07:08AM
Feb 24, 2026 07:00AM
Feb 17, 2026 07:00AM
Jan 8, 2026 04:30PM
Jan 8, 2026 04:30PM
Nov 5, 2025 07:18AM
Nov 5, 2025 07:00AM Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Oct 29, 2025 07:00AM
Aug 7, 2025 06:53AM
Aug 6, 2025 07:50AM
Aug 6, 2025 07:00AM
Jul 30, 2025 04:05PM
May 31, 2025 08:00AM
May 31, 2025 08:00AM Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
May 2, 2025 05:35AM
May 1, 2025 07:07AM
May 1, 2025 07:00AM
Apr 28, 2025 07:00AM
Mar 11, 2025 06:46AM
Mar 11, 2025 06:45AM
Feb 11, 2025 07:03AM Arvinas, Inc. (ARVN) Tops Q4 EPS by 33c
Feb 11, 2025 07:00AM
Feb 3, 2025 07:00AM
Dec 10, 2024 09:09AM
Dec 10, 2024 09:05AM
Oct 30, 2024 07:11AM
Oct 30, 2024 07:00AM
Oct 21, 2024 07:00AM Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024
Oct 1, 2024 06:47AM
Jul 30, 2024 09:30AM
Jul 30, 2024 07:00AM
May 16, 2024 06:01AM
May 16, 2024 06:00AM
May 7, 2024 07:33AM
May 7, 2024 07:00AM Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
Feb 27, 2024 07:00AM
Feb 6, 2024 06:46AM
Feb 6, 2024 06:45AM
Dec 5, 2023 01:36PM
Dec 5, 2023 01:33PM
Nov 28, 2023 05:05PM
Nov 7, 2023 07:21AM Arvinas, Inc. (ARVN) Tops Q3 EPS by 40c
Nov 7, 2023 07:00AM
Oct 15, 2023 06:05PM
Aug 8, 2023 07:02AM
Aug 8, 2023 07:00AM
Jul 31, 2023 04:30PM
Jul 31, 2023 04:30PM
May 8, 2023 07:00AM Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
May 5, 2023 07:42AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All